1-13 of 13
Authors: Murat Akova
Sort by
Journal Article
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study Open Access
Hongyu Zhou and others
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 9, September 2024, Pages 2132–2141, https://doi.org/10.1093/jac/dkae157
Published: 11 July 2024
Journal Article
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study Open Access
Abdullah Tarık Aslan and others
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 7, July 2023, Pages 1757–1768, https://doi.org/10.1093/jac/dkad167
Published: 02 June 2023
Journal Article
Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022 Open Access
Rafael Cantón and others
Journal of Antimicrobial Chemotherapy, Volume 77, Issue Supplement_1, September 2022, Pages i2–i9, https://doi.org/10.1093/jac/dkac211
Published: 06 September 2022
Journal Article
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae Free
Zaira Raquel Palacios-Baena and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 3, March 2017, Pages 906–913, https://doi.org/10.1093/jac/dkw513
Published: 20 December 2016
Journal Article
High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China Free
Jingjing Quan and others
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 273–280, https://doi.org/10.1093/jac/dkw372
Published: 13 September 2016
Journal Article
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study Free
Belén Gutiérrez-Gutiérrez and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 6, June 2016, Pages 1672–1680, https://doi.org/10.1093/jac/dkv502
Published: 22 February 2016
Journal Article
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort Free
Mohd H. Abdul-Aziz and others
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 1, January 2016, Pages 196–207, https://doi.org/10.1093/jac/dkv288
Published: 03 October 2015
Journal Article
Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006
Get access
Ignasi Roca and others
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 12, December 2014, Pages 3437–3438, https://doi.org/10.1093/jac/dku306
Published: 04 August 2014
Journal Article
A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease
Get access
Ronen Ben-Ami and others
Journal of Antimicrobial Chemotherapy, Volume 68, Issue suppl_3, November 2013, Pages iii25–iii33, https://doi.org/10.1093/jac/dkt390
Published: 01 November 2013
Journal Article
Comparative activity of carbapenem testing: the COMPACT study
Get access
Patrice Nordmann and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 5, May 2011, Pages 1070–1078, https://doi.org/10.1093/jac/dkr056
Published: 08 March 2011
Journal Article
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Get access
Livio Pagano and others
Journal of Antimicrobial Chemotherapy, Volume 66, Issue suppl_1, January 2011, Pages i5–i14, https://doi.org/10.1093/jac/dkq437
Published: 01 January 2011
Journal Article
Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-β-naphthylamide
Get access
Stefanie Pannek and others
Journal of Antimicrobial Chemotherapy, Volume 57, Issue 5, May 2006, Pages 970–974, https://doi.org/10.1093/jac/dkl081
Published: 10 March 2006
Journal Article
Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli
Get access
Anja Schumacher and others
Journal of Antimicrobial Chemotherapy, Volume 57, Issue 2, February 2006, Pages 344–348, https://doi.org/10.1093/jac/dki446
Published: 14 December 2005
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals